Deep Learning for Intelligent Identification of Arrhythmias (ECG-LEARNING)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT05967546 |
Recruitment Status :
Not yet recruiting
First Posted : August 1, 2023
Last Update Posted : April 4, 2024
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment |
---|---|
Arrhythmia | Other: Observational |
Study Type : | Observational |
Estimated Enrollment : | 4000 participants |
Observational Model: | Cohort |
Time Perspective: | Other |
Official Title: | Deep Learning for Intelligent Identification of Arrhythmias (ECG-LEARNING): an Investigator-initiated, National Multicenter, Retrospective-prospective, Cohort Study |
Estimated Study Start Date : | December 30, 2024 |
Estimated Primary Completion Date : | August 31, 2028 |
Estimated Study Completion Date : | December 31, 2028 |
Group/Cohort | Intervention/treatment |
---|---|
Experimental Group
ECG data and clinical data from this group of arrhythmia patients will be used to build a deep learning model.
|
Other: Observational
No interventions will be given to patients. |
- A deep learning model designed to intelligently identify the types of arrhythmia. [ Time Frame: 1 day after the enrollment. ]The model is trained on the training set, the best model and hyperparameters are selected through the verification set, and finally the model results are tested on the test set.
- The sensitivity, specificity and accuracy of the deep learning model [ Time Frame: 1 day after the enrollment. ]The sensitivity, specificity and accuracy of a deep learning model designed were evaluated by intracardiac electrophysiological examination results to identify patients with arrhythmia from various centers.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 3 Years and older (Child, Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- For retrospective study: 1.Patients with arrhythmia diagnosed by routine surface 12-lead electrocardiogram or Holter; 2.The type of arrhythmia is diagnosed by intracardiac electrophysiological examination.
- For prospective study: 1.Patients with arrhythmia diagnosed by routine surface 12-lead electrocardiogram or Holter; 2.Intracardiac electrophysiological examination is planned.
Exclusion Criteria:
- Lack of routine surface 12-lead electrocardiogram or holter data;
- Lack of intracardiac electrophysiological examination;
- Patients refused to sign informed consent and refused to participate in the study.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT05967546
Contact: Guoliang Li, M.D. | +8613759982523 | liguoliang_med@163.com | |
Contact: Chaofeng Sun, M.D. | cfsun1@mail.xjtu.edu.cn |
China, Shaanxi | |
First Affiliated Hospital of Xi'an Jiantong University | |
Xi'an, Shaanxi, China, 710061 |
Principal Investigator: | Guoliang Li, M.D. | First Affiliated Hospital Xi'an Jiaotong University |
Responsible Party: | First Affiliated Hospital Xi'an Jiaotong University |
ClinicalTrials.gov Identifier: | NCT05967546 |
Other Study ID Numbers: |
XJTU1AF2023LSK-170 |
First Posted: | August 1, 2023 Key Record Dates |
Last Update Posted: | April 4, 2024 |
Last Verified: | April 2024 |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
Arrhythmia |
Arrhythmias, Cardiac Heart Diseases Cardiovascular Diseases Pathologic Processes |